Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EYA4 antisense RNA 2 (EYA4-AS2) is a putative antisense noncoding RNA transcript complementary to the EYA4 gene; however, current genomic databases and the peer-reviewed literature do not substantiate its existence, characterization, or relevance as a therapeutic target. In general, antisense RNAs play regulatory roles in gene expression, chromatin structure, or epigenetic modification. EYA4 itself encodes a transcriptional coactivator and phosphatase, with crucial functions in hearing, cardiac development, DNA repair, apoptosis, and immunity. If EYA4-AS2 were functional, it might be involved in fine-tuning EYA4 gene expression through antisense-mediated processes, but no foundational data is available for this specific entity.
Nucleic acid hybridization; RNase H-mediated degradation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EYA4 antisense RNA 2 (EYA4-AS2).